Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 236,238 |
|
|||||
| News | - | ||||||
| Day High | 0.5667 | Low High |
|||||
| Day Low | 0.5081 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aligos Therapeutics Inc | ALGS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0101 | -1.87% | 0.53 | 18:42:15 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.5501 | 0.5081 | 0.5667 | 0.5399 | 0.5401 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 763 | 236,238 | US$ 0.5337171 | US$ 126,084 | - | 0.531 - 1.20 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:34:13 | 10 | US$ 0.53 | USD |
Aligos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 40.86M | 75.67M | - | 15.53M | -87.68M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aligos Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/05/2024 | 01:30 | GlobeNewswire Inc. | Aligos Therapeutics Presents Positive Data at the EASL.. |
| 5/31/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/22/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Announces Six Abstracts Accepted for.. |
| 5/22/2024 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/21/2024 | 07:00 | GlobeNewswire Inc. | Aligos Therapeutics Announces the Completion of Enrollment.. |
| 5/15/2024 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/07/2024 | 15:13 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/07/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/07/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Reports Recent Business Progress.. |
| 4/30/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics to Announce 1st Quarter 2024 Financial.. |
| 4/25/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Presents Positive Clinical Data at.. |
| 4/25/2024 | 07:00 | GlobeNewswire Inc. | Aligos Therapeutics Mourns the Passing of MASH Industry.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALGS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.61 | 0.64 | 0.531 | 0.5885721 | 303,092 | -0.08 | -13.11% |
| 1 Month | 0.7266 | 0.7545 | 0.531 | 0.6287965 | 274,505 | -0.1966 | -27.06% |
| 3 Months | 0.91 | 1.10 | 0.531 | 0.8264767 | 280,384 | -0.38 | -41.76% |
| 6 Months | 0.579 | 1.20 | 0.531 | 0.7967699 | 344,121 | -0.049 | -8.46% |
| 1 Year | 1.12 | 1.20 | 0.531 | 0.7906711 | 236,649 | -0.59 | -52.68% |
| 3 Years | 30.24 | 34.31 | 0.531 | 4.09 | 263,189 | -29.71 | -98.25% |
| 5 Years | 14.74 | 37.5099 | 0.531 | 5.85 | 238,968 | -14.21 | -96.40% |
Aligos Therapeutics Description
| Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. |
